Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction
NCP Cross, L Feng, J Bungey… - Leukemia & …, 1993 - Taylor & Francis
We describe the methodology and application of the polymerase chain reaction to detect
BCR-ABL mRNA as a marker for CML cells. The technique is highly sensitive enabling the …
BCR-ABL mRNA as a marker for CML cells. The technique is highly sensitive enabling the …
Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid …
JM Pignon, T Henni, S Amselem, M Vidaud… - Leukemia, 1990 - europepmc.org
The polymerase chain reaction (PCR) allows the detection of minimal amounts of nucleic
sequences and has been successfully used to test for the chronic myeloid leukemia-specific …
sequences and has been successfully used to test for the chronic myeloid leukemia-specific …
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow …
M Lee, I Khouri, R Champlin… - British journal of …, 1992 - Wiley Online Library
The prognostic significance of detecting minimal residual disease by polymerase chain
reaction (PCR) amplification of bcr/abl mRNA transcripts was investigated in 27 bone …
reaction (PCR) amplification of bcr/abl mRNA transcripts was investigated in 27 bone …
Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.
MH Delfau, JP Kerckaert, P Fenaux, JL Lai, JP Jouet… - Leukemia, 1990 - europepmc.org
We used a modification of the polymerase chain reaction (PCR) to amplify the specific bcr-
abl mRNA from 14 patients with chronic myeloid leukemia (CML) who had previously …
abl mRNA from 14 patients with chronic myeloid leukemia (CML) who had previously …
[HTML][HTML] Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse
We used the polymerase chain reaction (PCR) to detect residual leukemia-specific mRNA in
blood and marrow from 37 patients in complete hematologic and cytogenetic remission after …
blood and marrow from 37 patients in complete hematologic and cytogenetic remission after …
Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
S Mackinnon, L Barnett, G Heller - Bone marrow transplantation, 1996 - europepmc.org
In chronic myeloid leukemia (CML) the polymerase chain reaction (PCR) can be used to
detect minimal residual disease after bone marrow transplantation (BMT). Previous studies …
detect minimal residual disease after bone marrow transplantation (BMT). Previous studies …
Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients …
R Arnold, JW Janssen, B Heinze, D Bunjes… - Leukemia, 1993 - europepmc.org
To evaluate the remission quality of Philadelphia chromosome (Ph)-positive, BCR/ABL-
positive CML patients after allogeneic bone marrow transplantation (BMT) we used the …
positive CML patients after allogeneic bone marrow transplantation (BMT) we used the …
Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia
MS Roth, JH Antin, EL Bingham, D Ginsburg - 1989 - ashpublications.org
Sixteen patients treated by allogeneic bone marrow transplantation (BMT) for chronic
myelogenous leukemia (CML) were evaluated by the polymerase chain reaction (PCR) for …
myelogenous leukemia (CML) were evaluated by the polymerase chain reaction (PCR) for …
A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia
F Lin, JM Goldman, NCP Cross - British journal of haematology, 1994 - Wiley Online Library
We have sought to determine whether peripheral blood or bone marrow is more sensitive for
assessment of minimal residual disease in chronic myeloid leukaemia (CML) …
assessment of minimal residual disease in chronic myeloid leukaemia (CML) …
Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow …
W Lange, R Herkert, J Finke, U Ragoczy, W Siegert… - Annals of …, 1991 - Springer
A modified two-step polymerase chain reaction (PCR) was used for the amplification of
BCR/ABL mRNA in 16 patients with Philadelphia chromosomepositive (Ph+) chronic …
BCR/ABL mRNA in 16 patients with Philadelphia chromosomepositive (Ph+) chronic …